SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-24-077757
Filing Date
2024-07-03
Accepted
2024-07-03 16:01:19
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm2418807d1_s3.htm S-3 471240
2 EXHIBIT 1.1 tm2418807d1_ex1-1.htm EX-1.1 306372
3 EXHIBIT 4.3 tm2418807d1_ex4-3.htm EX-4.3 371385
4 EXHIBIT 5.1 tm2418807d1_ex5-1.htm EX-5.1 26504
5 EXHIBIT 23.1 tm2418807d1_ex23-1.htm EX-23.1 2546
6 EX-FILING FEES tm2418807d1_ex-filingfees.htm EX-FILING FEES 25900
7 GRAPHIC tm2418807d1_ex5-1img001.jpg GRAPHIC 2595
8 GRAPHIC tm2418807d1_s3img001.jpg GRAPHIC 5753
  Complete submission text file 0001104659-24-077757.txt   1216969
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: S-3 | Act: 33 | File No.: 333-280680 | Film No.: 241099986
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)